19
Nov
Share
No Comments on India’s indigenous solution to COVID-19 in progress Uncategorized
India’s indigenous solution to COVID-19 in progress
– Monoclonal Antibody Leads for COVID-19: A Way Forward In Combating COVID NAGPUR, India, Nov. 19, 2020 /PRNewswire/ — To fight the Novel coronavirus SARS-COV-2, the virus behind the worldwide outbreak of COVID-19 disease, a Nagpur based Indian biotechnology company, GeNext Genomics (GNG), is contributing[…]
Read More21
Jul
Share
No Comments on STAT 3: EYE CATCHER FOR DRUG RESISTANCE CANCER THERAPEUTICS Uncategorized
STAT 3: EYE CATCHER FOR DRUG RESISTANCE CANCER THERAPEUTICS
Signal Transducer and Activator of Transcription STAT proteins are intracellular transcription factors that mediate many aspects: Cellular immunity Proliferation Apoptosis Differentiation STAT 3 Gene STAT3 is considered as one of the most crucial member of the STAT family. STAT3 activation occurs via[...]
Read More02
Jul
Share
No Comments on Cytokines, major role in COVID-19 Prognosis Uncategorized
Cytokines, major role in COVID-19 Prognosis
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for an ongoing pandemic that has killed over 4,75,00 people globally and 14000 people alone in India. Also, the disease has paralyzed the global economy because of its devastating infection and widespread.[...]
Read More07
Jan
Share
No Comments on A Time and Cost-Effective Consistent Protein Production Platform Uncategorized
A Time and Cost-Effective Consistent Protein Production Platform
RESEARCH-GNG: Prashant Thakre, Chinmay Umbarkar, Komal Talreja, Sidhant Vyas, Jawad Baksh, Kalyani Dange, Akash Nehare, Vilas Danav, Ashwin Kashikar, Supriya Kashikar and Vinod Agarkar MARKETING-GNG: Mohammad Abdul, Rashmi Upadhyay and Supriya Kashikar Introduction Proteins are the most abundant macromolecules in the living[...]
Read MoreRecent Posts
India’s indigenous solution to COVID-19 in progress
